SCHEMBL24535888

SCHEMBL24535888

CNC(=O)c1cc2n(n1)CCCN(C(=O)OC(C)(C)C)C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 2/20 0.42
▸ HDAC6 Q9UBN7 3/20 0.42
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ ESR2 Q92731 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ MMP1 P03956 1/20 0.37
▸ MMP9 P14780 1/20 0.37
▸ MMP13 P45452 1/20 0.37
▸ TSHR P16473 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ S1PR2 O95136 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ RIN1 Q13671 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ PTPN2 P17706 1/20 0.36
▸ PTPN1 P18031 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24534817 0.90 NR1H2 (0.41) NR1H2HDAC6MEN1KMT2AESR2
SCHEMBL30793525 0.87 NR1H2 (0.41) NR1H2HDAC6MEN1KMT2AESR2
SCHEMBL25336926 0.87 NR1H2 (0.51) NR1H2HDAC6MEN1KMT2AESR2
SCHEMBL24535305 0.87 MEN1 (0.46) NR1H2HDAC6MEN1KMT2AESR2
SCHEMBL16102411 0.87 NR1H2 (0.42) NR1H2HDAC6MEN1KMT2AESR2
SCHEMBL29680742 0.87 HDAC6 (0.39) NR1H2HDAC6MEN1KMT2AESR2
SCHEMBL25335852 0.87 USP30 (0.43) NR1H2HDAC6MEN1KMT2APOLB
SCHEMBL30793276 0.86 USP30 (0.45) HDAC6MEN1KMT2APOLBKDM4E
SCHEMBL24536649 0.86 NR1H2 (0.42) NR1H2HDAC6MEN1KMT2AESR2
SCHEMBL30793862 0.85 NR1H2 (0.42) NR1H2HDAC6MEN1KMT2AESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4540254-A1 TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2025-04-23 — — EP disclosed
WO-2023244604-A1 TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2023-12-21 — — WO disclosed
EP-4262807-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2023-10-25 — — EP disclosed
WO-2022132200-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2022-06-23 — — WO disclosed
WO-2022132200-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2022-06-23 — — WO disclosed
Send feedback